Interview: Double Delight For ImmuPharma's Dimitriou
UK Biotech On The Up
Executive Summary
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.